MicroRNA 1909 (MIR1909)

MicroRNA 1909 is a short, non-coding RNA (approximately 20–24 nucleotides) encoded in the human genome. Like other microRNAs, it regulates gene expression post-transcriptionally by pairing with partially complementary sequences in target mRNAs, leading to translational repression or mRNA destabilization. While miR-1909 is not as widely studied as some other microRNAs, emerging evidence implicates it in disease contexts such as neuroepithelial tumors and in the modulation of cancer-relevant pathways, including Notch-1 signaling. Its expression pattern and functional associations make it a candidate for research as both a therapeutic target and biomarker, especially within oncology. MIR1909 is a validated human microRNA, not a protein or classical receptor, and thus is not suited to targeting by traditional small molecule drugs. Its roles and utility are mostly studied in the context of RNA-based molecular medicine and biomarker discovery rather than conventional pharmacology.

Other names

MIRN1909MIR-1909HSA-MIR-1909hsa-mir-1909mir-1909

Modulating expression of target mRNAs (e.g., Notch-1); Inhibiting translation or promoting decay of messenger RNAs post-transcriptionally.